SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charles Holewinski who wrote (5)11/13/1996 2:01:00 PM
From: Michael Collins   of 1115
 
Charles, remember I talked to you on the other Lidak thread initially
as I also receive BI Research and my favorite of their picks is Taseko.
As far as Lidak and the Bristol Myers Squibb agreement I believe that
BMS paid Lidak a $3 million dollar fee up front and also agreed to pay
royalties if Lidakol ever goes on the market. I will always keep an eye
on Lidak as I was a shareholder for a year and a half but I would have
to say it would take some drastic change in my mind's perception for
me to ever go back. I simply believe there are better opportunities
elsewhere without the big question marks that Lidak has.

Sincerely,

Michael Collins
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext